BACKGROUND In diabetic patients with multivessel coronary artery disease (CAD), the survival difference between
B
oth coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention (PCI) play a major role in the management of multivessel coronary artery disease (CAD) (1) (2) (3) (4) (5) . Since the introduction of drug-eluting stents (DES), PCI has become a widely used option for the treatment of multivessel CAD.
Several randomized trials comparing the relative outcomes of CABG versus PCI in patients with multivessel CAD have been published (6) (7) (8) (9) (10) (11) . In
From the a Division of Cardiology, Heart Institute, Asan Medical Center, University of Ulsan, Seoul, Republic of Korea; b Erasmus general, diabetic patients have poorer clinical outcomes than nondiabetic patients and better survival with CABG than PCI (6, 7, 9) .
However, controversy still exists as to the optimal revascularization strategy in nondiabetic patients with multivessel CAD. Death from any cause is undoubtedly the most unbiased endpoint to determine treatment strategy, but each randomized trial has shown limited power to assess the clinical equipoise between CABG and PCI regarding mortality. Pooling of patient-level data from these randomized trials might be suggested to increase the statistical power and allow time-to-event analysis of this issue (12) .
Therefore, in the present study, we combined the databases from the SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) and the BEST (Ran- Values are n (%). Percentages are on the basis of the number of nonmissing values.
ACE ¼ angiotensin-converting enzyme; ARB ¼ angiotensin II receptor blockers; other abbreviations as in Table 1 . Table 2) . Other medications were also less commonly used in the CABG group than in the PCI group. 
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A B B R E V I A T I O N S
DISCUSSION
Among nondiabetic patients with multivessel CAD, those who received CABG had a lower rate of death from any cause than those who underwent PCI with DES (Central Illustration). Furthermore, the rate of myocardial infarction was remarkably lower after CABG than after PCI with DES. These benefits on both the primary outcome and myocardial infarction were consistent across all major clinical subgroups. In contrast, the risk of stroke linked to CABG was relatively small.
Understanding long-term mortality may help physicians to decide the best treatment strategy for a particular patient. In addition, all-cause mortality may be the most reliable endpoint because it is not affected by bias in classifying the cause of death. However, previous randomized trials were typically not powered to detect a small difference in all-cause mortality. In the present study, therefore, databases from 2 randomized trials were merged to overcome the power limitation of the individual studies. Five-year survival was found to be significantly better in the CABG group than the PCI group in nondiabetic patients with multivessel CAD. There was no between-group difference within the first few months after randomization, but the difference progressively increased over time, were calculated using the log-rank test with all available follow-up data. Percentages denote 5-year event rates. Abbreviations as in Figure 1 .
demonstrating a clear survival advantage for CABG.
This finding is consistent with the results of previous randomized trials (7, 9, 13, 14) . In the largest observa- Despite the use of sophisticated statistical techniques, observational data are confounded by selection biases, often yielding mixed outcomes. In our study, the results were derived from a large pooled population of randomized studies and showed that CABG was associated with progressively better survival than PCI with DES. We also found that in patients with low SYNTAX scores, the 2 strategies were comparable with respect to mortality, but in those with intermediate or high SYNTAX scores, CABG was distinctly superior to PCI with DES. These findings support that CABG is the preferred approach for patients with multivessel CAD, and that PCI may be a valid option for selected low-risk patients with multivessel CAD.
For secondary outcomes, the incidence of myocardial infarction was markedly different between CABG and PCI. The cumulative incidence of myocardial infarction tended to reach a plateau soon after CABG, whereas it continued to accrue over time after PCI with DES. These findings are compatible with those from previous studies (17) , supporting the Post-operative stroke is a devastating complication with high morbidity and mortality. Previously, the risk of early stroke was shown to be greater with CABG than with PCI, but the incidence of late stroke was similar (19) . On the contrary, we found that stroke rarely occurred, and there was no significant difference between the 2 strategies. A similar finding was observed by other investigators, which should provide some reassurance to patients undergoing CABG (20) . The reason for these discrepancies remains unclear, but differences in study design, pa- 
